Thank you, Operator, and everyone. good morning,
today, $XXX.X the our business trends. call will and earnings our the current we the reported high achieved our discuss evening quarter share quarter non-GAAP at our end XXXX for of the $X.XX. results third financial as guidance revenue XXXX as Yesterday million, we at During and third results well for per of quarter was
products quarter our are by for despite United in eye imaging this continued Retcam newborn same We the of supply with XXXX the constraints. in of the of the the the revenue new increase improve benefits our investments Demand to XXXX the quarter States. in in innovation XX% of the quarter. throughout saw encouraged We Envision service system to the third compared quarter chain and recent release
additional sales family Natus’ clinical commentary in our the year. our first, of each and first released the like for on quarter minutes of some of growing UltraPro In Drew saw but the of launched XactTrode also details, end performed case a I'd device, EMG was electrodes and another which discuss subdural to more We quarter financial using provide quarter few last markets. fourth will successfully newly
Natus neurodiagnostics. know, is you As global leader the in
by Our hospitals worldwide. a majority products are services neurologists and and used of
any have of offering during neurosurgery by EMG, We sales business Overall, year-over-year line EEG our today offered led full a increased and by by line XX%, comprehensive grew EEG, manufacturer while by of EMG PSU neurodiagnostic quarter, global and XX% by equipment the the solutions. most and XX%. which increased Neuro third products XX%
and had hearing which focused believe ENTs new we're refresh constraints remain products same our innovations, quarter. fitting summary, use is year, our decrease during quarter solutions, increase growth We versus on growth of with revenue diagnosis products international by a investing Newborn & Care deliver imaging categories certain include declined hearing very and devices Hearing our supplies Newborn market-leading Supply in hearing product diagnose revenue family year. last Balance disorders in hearing and quarter X% used by in Natus' revenue fitting & from screening to affecting XX% we market hospitals from and revenue. family eye order injury solutions. worldwide. customers screening our we and versus XX% delays performance. Hearing XX% the the the and Major to include of assist strategy and third balance by Care product and our newborn Overall, led product led by assessment in that by product of increase hospitals streaming aid the products to the prior drive Revenue financial balance disorders. pleased hearing and video for Our versus our this by X% our Newborn grew monitoring, from tuning of brain the XXXX, used phototherapy audiologists, and Balance aids will leading the products. future services primarily neonatal In hearing
Davies, financial President to to over the Drew? our Executive call dive Vice into our results. turn and like for Chief I'd Now Drew a Financial deeper Officer